Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-10-29 | Amended | $250,000 | $150,000 | Equity Only | 06b | SEC link |
| 2024-06-06 | New | $100,000 | $100,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Jonathan S. Bromberg | Executive |
| Christopher Jewell | Director, Executive |